Literature DB >> 11968446

Progressive myoclonus epilepsy with polyglucosan bodies: Lafora disease.

Berge A Minassian1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11968446

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


× No keyword cloud information.
  16 in total

1.  Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22.

Authors:  E M Chan; D E Bulman; A D Paterson; J Turnbull; E Andermann; F Andermann; G A Rouleau; A V Delgado-Escueta; S W Scherer; B A Minassian
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

Review 2.  Young onset dementia.

Authors:  E L Sampson; J D Warren; M N Rossor
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

Review 3.  Progressive myoclonic epilepsies: review of clinical, molecular and therapeutic aspects.

Authors:  Luis Felipe Mendonça de Siqueira
Journal:  J Neurol       Date:  2010-07-01       Impact factor: 4.849

4.  Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.

Authors:  Matthew S Gentry; Carolyn A Worby; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-01       Impact factor: 11.205

Review 5.  Lafora disease, seizures and sugars.

Authors:  D M Andrade; J Turnbull; B A Minassian
Journal:  Acta Myol       Date:  2007-07

6.  Dimeric quaternary structure of human laforin.

Authors:  Rajeshwer S Sankhala; Adem C Koksal; Lan Ho; Felix Nitschke; Berge A Minassian; Gino Cingolani
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

7.  Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.

Authors:  Yin Wang; Keli Ma; Peixiang Wang; Otto Baba; Helen Zhang; Jack M Parent; Pan Zheng; Yang Liu; Berge A Minassian; Yan Liu
Journal:  Mol Neurobiol       Date:  2013-04-02       Impact factor: 5.590

8.  NHLRC1 repeat expansion in two beagles with Lafora disease.

Authors:  I Hajek; F Kettner; V Simerdova; C Rusbridge; P Wang; B A Minassian; V Palus
Journal:  J Small Anim Pract       Date:  2016-10-16       Impact factor: 1.522

9.  Molecular dynamics simulations and principal component analysis on human laforin mutation W32G and W32G/K87A.

Authors:  P S Srikumar; K Rohini; Perumbilavil Kaithamanakallam Rajesh
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

10.  Lafora disease as a cause of visually exacerbated myoclonic attacks in a dog.

Authors:  Aubrey A Webb; Chantal McMillan; Cheryl L Cullen; Sarah E Boston; Julie Turnbull; Berge A Minassian
Journal:  Can Vet J       Date:  2009-09       Impact factor: 1.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.